Search results for: treatment
Applied Therapeutics
Applied Therapeutics is a biopharmaceutical company dedicated to creating transformative treatments to address high unmet...
ANANDA Devices
At Ananda Devices, they collaborate with businesses worldwide, spanning across Canada, the United States, Europe,...
2025 CMTA Patient & Research Summit
Saturday Welcome Address Sue Bruhn, PhD IU Health CMT Clinic Team Laurie Gutmann, MD Meet...
What Happens When Scientists Flip the Switch on PMP22?
What happens when scientists flip a hidden switch inside nerve cells? A CMTA-funded $281,339 study is testing whether this discovery could finally bring new treatment options for people with CMT1A.
Modulating TEAD1 Activity in Charcot-Marie-Tooth Disease Type 1A
With CMTA support of $281,339, researchers at Albany Medical College, led by Sophie Belin, PhD, and Yannick Poitelon, PhD, are exploring the newly discovered TEAD1 pathway in Schwann cells that may regulate PMP22, the gene at the root of CMT1A.
Actio Biosciences
Actio Biosciences is developing precision medicines for the treatment of rare genetic diseases, including CMT...
Charcot-Marie-Tooth disease Infant Scale: INC Research Study 6611
The Charcot-Marie-Tooth Association (CMTA), through its strategic alliance with the Inherited Neuropathy Consortium (INC), is...
Genetics of Charcot Marie Tooth Disease: INC Research Study 6602
CMTA-Funded Research Database for CMT2 Identifies New Disease-Causing Mutations While researchers have identified more than...
Greg Stilwell
Greg Stilwell, DPM, is a board-certified podiatrist diagnosed with CMT 1A, an inventor and a...
Patricia Sciscione
Patricia Sciscione, PhD, RN, CSN-NJ, is an Assistant Professor in the Marjorie K. Unterberg School...
